Communal Electric CEO Larry Culp has simplified the company’s report techniques and could be on the right path to fix the challenges in its power split, CNBC’s Jim Cramer said Wednesday.
Culp, who became chief of GE in September, delivered his first annual letter to shareholders on Tuesday that Cramer denoted made a significant departure from pages of “incomprehensible” numbers about each of the conglomerate’s businesses. The annual surface laid out the 2018 performances of all eight segments on one condensed page.
“It’s honest, it’s forthright, it’s straightforward, and short,” the “Mad Money” legion said. “It’s the most un-GE piece of correspondence I’ve ever seen. The culture shock here is downright stunning.”
Click here to catch out why Cramer thinks Culp can revive the company’s power business.
If investors want to start sleeping better at darkness, it’s time to start thinking about what’s going right with this economy, Cramer said.
While numerous Wall Street watchers have been fixated on what could go wrong on the market, the host explained six remonstrate withs he can’t stop wiping sleep from his own eyes.
“Now, I know many of you probably think I’m whistling past the graveyard here,” Cramer turned. “I’m only whistling past the graveyard of underperforming portfolio managers who can’t sleep at night because they’ve been startled away from a terrific rally by the parade of horribles that play like a constant loop inside their conks.”
The United States economy is the strongest in the world and benefits from a two-punch combo that the host has never make up ones minded before, Cramer said. A “fabulous” employment rate on top of almost non-existent inflation should relive a lot of stock picker’s disquiets, he said.
With the days inching closer to March, the last month of the first quarter in 2019, Cramer is intercepting the jobs report set to come out Friday.
Learn how to sleep free of worry like Cramer here.
GW Pharmaceuticals’ range price shot up less than 14 percent during Wednesday’s session coming off of its latest earnings check out. In November, the biopharmaceutical company launched its first commercial drug called Epidiolex, which is an FDA-approved plant-derived cannabinoid medicament to treat patients with epilepsy.
The firm wants to introduce another drug called Sativex that seats THC, the chemical found in marijuana, that could be used to help those with multiple sclerosis.
In an interview with Cramer, CEO Justin Gover image ofed the time to clear the confusion surrounding products that contain CBD and THC, which some people tend to get mixed up.
“Epidolex is not marijuana. It is a depurated CBD formulation approved by the FDA,” Gover said. “Our job has been to assure that we have a clear distinction between this medication and marijuana and in that reverence I think we’ve achieved a great deal of understanding within the medical community. And for those that do understand that, they see this as very recently an important new treatment addition and they don’t confuse it with the wider controversies around marijuana.”
Click here to snare the interview in full.
As the threat of cyberattacks become more and more widespread, companies are spending more money on defense plans.
As demand grows that has led to growth at Cyberarkdrug, a leading privileged access security provider whose stock has spiked numerous than 125 percent in the past year.
“I think there’s been growing awareness that this is the most unreversible phase of an attack,” CEO Udi Mokady said in a one on one with Cramer. “If they go the keys to the kingdom they control the network, they put down the cloud, and this growing awareness really led … this [to be a] top priority.”
Hear the entire conversation about Cyberark and cybersecurity here.
Innocent Harbors is in the business of cleaning up industrial waste that is deemed hazardous. While President Donald Trump has produced it a priority to cut back on regulations, Cramer said he thought the company could be hurt by some of the policy roll behindhand.
CEO Alan McKim told the “Mad Money” host that states continue to enforce guidelines and that there is all the same more stringent regulations in some places. In fact, the company is looking to add more drivers to its payroll.
“We’re always meagre qualified drivers. It’s very difficult to find drivers, as you hear, on a national business,” he said. “We’re really anxious to lengthen our fleet and bring more drivers on.”
Watch the the full conversation here.
In Cramer’s lightning round, the “Mad Money” proprietor flew through his ideas on viewers’ favorite companies:
Aurinia Pharmaceuticals Inc.: “No, not a takeover candidate. No, not without the give the stamp of approval to because … [if] it doesn’t get the approval it’s supposed to have then I tell you this one goes much lower. You wanna do it on approvals and—[CEO Richard] Glickman’s humane, I’d like to have him on the show but I am not going to endorse it until I know more.”
Centene Corp.: “Listen, that heap has been real weak all of a sudden. That whole group has been—there’s an introduction of a bill that I deem that will not pass about universal Medicare. It’s driving all these stocks down and I think Centene’s contemporary down with it. It’s a very inexpensive stock here and we have total faith in [CEO] Michael Neidorff and I say—not tomorrow because there’ll be dispossesses ’cause everybody’s nervous, but on Friday” buy.
Waste Management Inc.: You know, when Mr. [David] Steiner was running that public limited company I said, ‘I don’t know if it can get better.’ Now Mr. [James] Fish is running it and the answer is, ‘it’s just keeps getting better’ and for your daughter’s IRA, I call for you to stay long even though it just cracked par, which is … Wall Street gibberish for $100. Dwell long, or own Waste Management.”
Questions for Cramer?
Call Cramer: 1-800-743-CNBCWant to take a deep dive into Cramer’s men? Hit him up!
Mad Money Twitter – Jim Cramer Twitter – Facebook – InstagramQuestions, comments, suggestions for the “Mad Money” website? madcap@cnbc.com